{"id":118487,"date":"2023-11-05T23:45:13","date_gmt":"2023-11-05T23:45:13","guid":{"rendered":"https:\/\/dailytalks.org\/?p=118487"},"modified":"2023-11-05T23:45:13","modified_gmt":"2023-11-05T23:45:13","slug":"gsks-cancer-drug-jemperli-meets-overall-survival-goal-in-late-stage-trial","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=118487","title":{"rendered":"GSK&#8217;s cancer drug Jemperli meets overall survival goal in late-stage trial"},"content":{"rendered":"<p>British drugmaker GSK <a target=\"_blank\" rel=\"noopener\">https:\/\/www.reuters.com\/markets\/companies\/GSK.L&#8221;<\/a> target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>(GSK.L)<\/a> said on Monday its cancer drug Jemperli when combined with chemotherapy, met the primary goal of overall survival in patients with advanced or recurren\u2026<br \/><a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/gsk-says-endometrial-cancer-drug-meets-primary-goal-late-stage-trial-2023-10-30\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>British drugmaker GSK https:\/\/www.reuters.com\/markets\/companies\/GSK.L&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>(GSK.L) said on Monday its cancer drug Jemperli when combined<\/p>\n","protected":false},"author":1,"featured_media":118488,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-118487","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lse-mrkt"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/11\/118487-gsks-cancer-drug-jemperli-meets-overall-survival-goal-in-late-stage-trial.jpg",1200,628,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/11\/118487-gsks-cancer-drug-jemperli-meets-overall-survival-goal-in-late-stage-trial-150x150.jpg",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/11\/118487-gsks-cancer-drug-jemperli-meets-overall-survival-goal-in-late-stage-trial-300x157.jpg",300,157,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/11\/118487-gsks-cancer-drug-jemperli-meets-overall-survival-goal-in-late-stage-trial-768x402.jpg",640,335,true],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/11\/118487-gsks-cancer-drug-jemperli-meets-overall-survival-goal-in-late-stage-trial-1024x536.jpg",640,335,true],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/11\/118487-gsks-cancer-drug-jemperli-meets-overall-survival-goal-in-late-stage-trial.jpg",1200,628,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/11\/118487-gsks-cancer-drug-jemperli-meets-overall-survival-goal-in-late-stage-trial.jpg",1200,628,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/11\/118487-gsks-cancer-drug-jemperli-meets-overall-survival-goal-in-late-stage-trial-1024x536.jpg",1024,536,true],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/11\/118487-gsks-cancer-drug-jemperli-meets-overall-survival-goal-in-late-stage-trial-825x575.jpg",825,575,true],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/11\/118487-gsks-cancer-drug-jemperli-meets-overall-survival-goal-in-late-stage-trial-590x410.jpg",590,410,true]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=26\" rel=\"category\">London Market<\/a>","tag_info":"London Market","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/118487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=118487"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/118487\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/118488"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=118487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=118487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=118487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}